Search

Your search keyword '"Fernández-Cruz, Eduardo"' showing total 190 results

Search Constraints

Start Over You searched for: Author "Fernández-Cruz, Eduardo" Remove constraint Author: "Fernández-Cruz, Eduardo"
190 results on '"Fernández-Cruz, Eduardo"'

Search Results

1. Early trajectories of virological and immunological biomarkers and clinical outcomes in patients admitted to hospital for COVID-19: an international, prospective cohort study

2. Hyperimmune immunoglobulin for hospitalised patients with COVID-19 (ITAC): a double-blind, placebo-controlled, phase 3, randomised trial

3. Tixagevimab–cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial

4. Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial

5. Hyperimmune immunoglobulin for hospitalised patients with COVID-19 (ITAC): a double-blind, placebo-controlled, phase 3, randomised trial

7. Evolution and molecular interactions of major histocompatibility complex (MHC)-G, -E and -F genes

8. Semi-supervised mixture multi-source exchangeability model for leveraging real-world data in clinical trials.

9. Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG): a double-blind, randomised, placebo-controlled trial

10. Lack of Specific Immune Response after Five Doses of mRNA SARS-CoV-2 Vaccine in a Patient with CD4 + T-Cell Lymphopenia but Preserved Responses to CMV.

12. Comparison of the Outcomes of Individuals With Medically Attended Influenza A and B Virus Infections Enrolled in 2 International Cohort Studies Over a 6-Year Period: 2009–2015

13. Tixagevimab–cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial

14. Tixagevimab–cilgavimab for treatment of patients hospitalised with COVID-19:a randomised, double-blind, phase 3 trial

15. Hyperimmune immunoglobulin for hospitalised patients with COVID-19 (ITAC):a double-blind, placebo-controlled, phase 3, randomised trial

17. HLA-G: Too Much or Too Little? Role in Cancer and Autoimmune Disease

18. HLA-G 3’UTR Polymorphisms Are Linked to Susceptibility and Survival in Spanish Gastric Adenocarcinoma Patients

19. RCT Abstract - Randomized, double-blind, placebo-controlled, phase III clinical trial with MV130, a sublingual bacterial immunotherapy to prevent COPD exacerbations

24. Experience in IVIg Therapy for Selected Women with Recurrent Reproductive Failure and NK Cell Expansion

25. HLA‐G in Mayas from Yucatan: An evolutionary approach

28. Intravenous Immunoglobulin Treatment Increased Live Birth Rate in a Spanish Cohort of Women with Recurrent Reproductive Failure and Expanded CD56+ Cells

30. A leaky mutation in CD3D differentially affects αβ and γδ T cells and leads to a Tαβ–Tγδ+B+NK+ human SCID

46. Curso rápidamente progresivo de Hepatitis por virus C en pacientes con hipogammaglobulina y deficiencia de la inmunidad celular

50. Evaluation of humoral immunity profiles to identify heart recipients at risk for development of severe infections: a multicenter prospective study

Catalog

Books, media, physical & digital resources